Guardant Health (GH) Short Interest Ratio & Short Volume $36.15 +0.27 (+0.75%) As of 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends Guardant Health Short Interest DataGuardant Health (GH) has a short interest of 8.25 million shares. This marks a -10.03% decrease in short interest from the previous month. The short interest ratio (days to cover) is 4.7, indicating that it would take 4.7 days of the average trading volume of 2.21 million shares to cover all short positions.Current Short Interest8,250,000 sharesPrevious Short Interest9,170,000 sharesChange Vs. Previous Month-10.03%Dollar Volume Sold Short$286.77 millionShort Interest Ratio4.7 Days to CoverLast Record DateDecember 15, 2024Outstanding Shares123,555,000 sharesPercentage of Shares Shorted6.68%Today's Trading Volume1,877,027 sharesAverage Trading Volume2,214,857 sharesToday's Volume Vs. Average85% Short Selling Guardant Health? Sign up to receive the latest short interest report for Guardant Health and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGH Short Interest Over TimeGH Days to Cover Over TimeGH Percentage of Float Shorted Over Time Ad Wyatt Investment ResearchBofA Reveals New $1.4 Trillion OpportunityEveryone is focusing on AI stocks... Yet little-known "space stocks" are rocketing to record highs with gains of 588% - 3,710%! One new space stock that I call "the next SpaceX" is preparing to IPO on the NASDAQ. Right now, you can grab Pre-IPO shares for less than $4.00. And my estimates suggest the valuation could soar 457% with the IPO. Get urgent details inside this free report...The Next SpaceX Pre-IPO Guardant Health Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/15/20248,250,000 shares $286.77 million -10.0%N/A4.7 $34.76 11/30/20249,170,000 shares $326.54 million -2.3%N/A4.7 $35.61 11/15/20249,390,000 shares $273.34 million -8.5%N/A4.4 $29.11 10/31/202410,260,000 shares $224.49 million -25.0%N/A4.9 $21.88 10/15/202413,680,000 shares $294.94 million -0.1%N/A6.1 $21.56 9/30/202413,690,000 shares $314.05 million +20.6%N/A6.1 $22.94 Get the Latest News and Ratings for GH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Guardant Health and its competitors with MarketBeat's FREE daily newsletter. 9/15/202411,350,000 shares $304.07 million +2.1%N/A5.1 $26.79 8/31/202411,120,000 shares $284.45 million +18.4%N/A5.4 $25.58 8/15/20249,390,000 shares $267.99 million +34.3%N/A4.4 $28.54 7/31/20246,990,000 shares $245.56 million +2.2%N/A3 $35.13 7/15/20246,840,000 shares $215.73 million -13.0%N/A3.4 $31.54 6/30/20247,860,000 shares $227.00 million +3.0%N/A3.8 $28.88 6/15/20247,630,000 shares $230.50 million -8.1%N/A3.3 $30.21 5/31/20248,300,000 shares $224.93 million -22.9%N/A3.5 $27.10 5/15/202410,760,000 shares $277.07 million +5.9%N/A4.7 $25.75 4/30/202410,160,000 shares $182.88 million +6.3%N/A5.3 $18.00 4/15/20249,560,000 shares $163.09 million +25.1%N/A4.8 $17.06 3/31/20247,640,000 shares $157.61 million -1.6%N/A4 $20.63 3/15/20247,760,000 shares $137.66 million +10.1%N/A4.8 $17.74 2/29/20247,050,000 shares $133.95 million +24.1%N/A4.3 $19.00 2/15/20245,680,000 shares $125.70 million +2.5%N/A3.6 $22.13 1/31/20245,540,000 shares $121.49 million +4.1%N/A3.5 $21.93 1/15/20245,320,000 shares $128.74 million +1.7%N/A3.2 $24.20 12/31/20235,230,000 shares $141.47 million -4.7%N/A3.3 $27.05 12/15/20235,490,000 shares $154.76 million -4.4%N/A3.3 $28.19 11/30/20235,740,000 shares $144.48 million -9.5%N/A3.4 $25.17 11/15/20236,340,000 shares $144.68 million -9.4%N/A3.5 $22.82 10/31/20237,000,000 shares $181.16 million -5.0%N/A4.2 $25.88 10/15/20237,370,000 shares $199.21 million +5.1%N/A4.6 $27.03 9/30/20237,010,000 shares $207.78 million +1.5%N/A4.5 $29.64 9/15/20236,910,000 shares $204.05 million -1.4%N/A4.5 $29.53 8/31/20237,010,000 shares $273.95 million +2.5%N/A4 $39.08 8/15/20236,840,000 shares $242.07 million -8.2%N/A3.4 $35.39 7/31/20237,450,000 shares $290.70 million -9.3%N/A3.4 $39.02 7/15/20238,210,000 shares $314.61 million -4.8%N/A3.8 $38.32 6/30/20238,620,000 shares $308.60 million +13.1%N/A4 $35.80 6/15/20237,620,000 shares $288.49 million +10.0%N/A3.5 $37.86 5/31/20236,930,000 shares $203.19 million -2.4%N/A3.4 $29.32 5/15/20237,100,000 shares $198.02 million +11.1%7.3%3.5 $27.89 4/30/20236,390,000 shares $144.16 million -8.6%6.5%3.3 $22.56These guys expect TSLA to reach $700 a share by August (Ad)Twitter lit up this morning after someone put a $4,000,000 bet on TSLA. These guys lit up the $700 strike calls for August 2025… This is odd, considering Tesla only trades for around $350 a share today… In other words, these guys are betting that Tesla’s stock will surge by 100% over the months ahead. In my opinion, that’s an incredibly risky bet. A lot can happen between now and then… Besides, there is a better way to target that same 100% return without waiting until August.If you’d like to see how to execute the trade this coming Thursday, follow this link. 4/15/20236,990,000 shares $171.26 million +3.4%7.2%3.7 $24.50 3/31/20236,760,000 shares $158.45 million +7.1%6.9%3.4 $23.44 3/15/20236,310,000 shares $168.98 million -9.9%6.5%3.1 $26.78 2/28/20237,000,000 shares $216.23 million +13.1%7.2%3.4 $30.89 2/15/20236,190,000 shares $179.32 million +11.9%6.3%3.2 $28.97 1/31/20235,530,000 shares $173.81 million -0.4%6.1%3.3 $31.43 1/15/20235,550,000 shares $168.89 million +8.8%5.7%3.5 $30.43 12/30/20225,100,000 shares $138.72 million +18.9%5.3%3.3 $27.20 12/15/20224,290,000 shares $177.01 million +3.9%4.4%3.1 $41.26 11/30/20224,130,000 shares $216.16 million -1.9%4.3%4.1 $52.34 11/15/20224,210,000 shares $215.76 million +5.5%4.4%4.1 $51.25 10/31/20223,990,000 shares $197.51 million +1.8%4.1%4 $49.50 10/15/20223,920,000 shares $191.14 million +4.3%4.1%4 $48.76 9/30/20223,760,000 shares $202.40 million -12.2%3.9%4.1 $53.83 9/15/20224,280,000 shares $252.05 million -7.2%4.5%4.6 $58.89 8/31/20224,610,000 shares $230.78 million +3.1%4.8%4.5 $50.06 8/15/20224,470,000 shares $246.03 million +5.9%4.6%4 $55.04 7/31/20224,220,000 shares $211.72 million +7.9%4.4%2.9 $50.17 7/15/20223,910,000 shares $190.46 million -2.3%4.1%2.6 $48.71 6/30/20224,000,000 shares $161.36 million -7.2%4.2%2.8 $40.34 6/15/20224,310,000 shares $165.59 million +7.5%4.5%3 $38.42 5/31/20224,010,000 shares $164.33 million +16.2%4.2%2.9 $40.98 5/15/20223,450,000 shares $123.89 million -11.8%3.6%2.5 $35.91 4/30/20223,910,000 shares $241.25 million +3.2%4.1%3.5 $61.70 4/15/20223,790,000 shares $272.84 million +0.8%4.0%3.6 $71.99 3/31/20223,760,000 shares $249.06 million -1.1%N/A0 $66.24 3/15/20223,800,000 shares $185.29 million -1.8%4.0%3.3 $48.76 2/28/20223,870,000 shares $256.46 million +13.2%4.1%3.3 $66.27 2/15/20223,420,000 shares $247.54 million -15.6%3.6%2.8 $72.38 1/31/20224,050,000 shares $281.68 million -4.5%4.3%3.3 $69.55 1/15/20224,240,000 shares $328.94 million +0.7%N/A3.6 $77.58 12/31/20214,210,000 shares $421.08 million -12.3%4.4%4 $100.02 12/15/20214,800,000 shares $463.39 million +11.4%5.1%4.3 $96.54 11/30/20214,310,000 shares $453.07 million +8.8%4.5%4.2 $105.12 11/15/20213,960,000 shares $410.45 million +5.9%4.2%4 $103.65 10/29/20213,740,000 shares $436.79 million -13.0%3.9%4.1 $116.79 10/15/20214,300,000 shares $436.88 million -7.1%4.5%4.7 $101.60 9/30/20214,630,000 shares $578.80 million +7.2%4.9%5.2 $125.01 9/15/20214,320,000 shares $548.64 million +3.4%4.6%5.5 $127.00 8/31/20214,180,000 shares $531.99 million +9.7%4.4%4.8 $127.27 8/13/20213,810,000 shares $385.88 million +16.2%4.0%4.3 $101.28 7/30/20213,280,000 shares $360.14 million -4.4%3.4%3.4 $109.80 7/15/20213,430,000 shares $389.72 million -12.7%3.6%3.6 $113.62 6/30/20213,930,000 shares $488.07 million +3.7%4.1%4 $124.19 6/15/20213,790,000 shares $446.05 million -4.8%4.2%3.9 $117.69 5/28/20213,980,000 shares $494.00 million -5.2%4.4%4.3 $124.12 5/14/20214,200,000 shares $461.03 million +1.0%4.7%4.2 $109.77 4/30/20214,160,000 shares $668.51 million -16.5%4.6%4.2 $160.70 4/15/20214,980,000 shares $772.05 million +0.6%N/A0 $155.03 3/31/20214,950,000 shares $726.61 million -0.6%5.6%4.7 $146.79These guys expect TSLA to reach $700 a share by August (Ad)Twitter lit up this morning after someone put a $4,000,000 bet on TSLA. These guys lit up the $700 strike calls for August 2025… This is odd, considering Tesla only trades for around $350 a share today… In other words, these guys are betting that Tesla’s stock will surge by 100% over the months ahead. In my opinion, that’s an incredibly risky bet. A lot can happen between now and then… Besides, there is a better way to target that same 100% return without waiting until August.If you’d like to see how to execute the trade this coming Thursday, follow this link. 3/15/20214,980,000 shares $711.94 million +29.7%5.6%4.6 $142.96 2/26/20213,840,000 shares $573.89 million +3.5%4.3%3.4 $149.45 2/12/20213,710,000 shares $624.43 million +11.4%4.2%3.7 $168.31 1/29/20213,330,000 shares $521.74 million -17.0%3.9%3.1 $156.68 1/15/20214,010,000 shares $630.65 million +7.5%4.7%3.9 $157.27 12/31/20203,730,000 shares $470.50 million +13.0%4.4%3.6 $126.14 12/15/20203,300,000 shares $402.53 million +4.4%3.8%3.3 $121.98 11/30/20203,160,000 shares $374.97 million +66.3%3.7%3.1 $118.66 11/15/20201,900,000 shares $220.70 million -8.7%2.2%1.9 $116.16 10/30/20202,080,000 shares $228.13 million -2.8%2.4%2.3 $109.68 10/15/20202,140,000 shares $227.42 million -8.9%2.5%2.3 $106.27 9/30/20202,350,000 shares $262.68 million +6.3%3.0%2.6 $111.78 9/15/20202,210,000 shares $227.85 million -12.3%2.8%2.6 $103.10 8/31/20202,520,000 shares $240.66 million -4.6%3.3%3.1 $95.50 8/14/20202,640,000 shares $225.61 million -1.1%3.5%2.6 $85.46 7/31/20202,670,000 shares $227.43 million -5.3%3.5%2.6 $85.18 7/15/20202,820,000 shares $234.68 million -14.6%3.9%2.7 $83.22 6/30/20203,300,000 shares $267.73 million +39.2%4.7%3.1 $81.13 6/15/20202,370,000 shares $192.11 million +4.0%3.4%2.3 $81.06 5/29/20202,280,000 shares $206.09 million -1.7%3.6%2 $90.39 5/15/20202,320,000 shares $226.20 million -23.2%3.8%1.9 $97.50 4/30/20203,020,000 shares $232.42 million -12.7%3.7%2.4 $76.96 4/15/20203,460,000 shares $233.48 million +3.9%6.4%2.9 $67.48 3/31/20203,330,000 shares $253.71 million -19.5%6.2%2.7 $76.19 3/13/20204,136,700 shares $284.89 million -10.3%7.7%2.3 $68.87 2/28/20204,610,000 shares $276.23 million +41.4%8.6%4 $59.92 2/14/20203,260,000 shares $221.19 million +6.5%6.1%3.4 $67.85 1/31/20203,060,000 shares $249.39 million -12.8%5.8%3.4 $81.50 1/15/20203,510,000 shares $276.10 million -8.1%7.0%3.7 $78.66 GH Short Interest - Frequently Asked Questions What is Guardant Health's current short interest? Short interest is the volume of Guardant Health shares that have been sold short but have not yet been closed out or covered. As of December 15th, investors have sold 8,250,000 shares of GH short. Learn More on Guardant Health's current short interest. What is a good short interest ratio for Guardant Health? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GH shares currently have a short interest ratio of 5.0. Learn More on Guardant Health's short interest ratio. Which institutional investors are shorting Guardant Health? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Guardant Health: Jane Street Group LLC, Wolverine Trading LLC, Parallax Volatility Advisers L.P., Walleye Trading LLC, Walleye Capital LLC, and Wolverine Asset Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Guardant Health's short interest increasing or decreasing? Guardant Health saw a decline in short interest during the month of December. As of December 15th, there was short interest totaling 8,250,000 shares, a decline of 10.0% from the previous total of 9,170,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Guardant Health's short interest compare to its competitors? Here is how the short interest of companies in the industry of "healthcare" compare to Guardant Health: Fresenius Medical Care AG (0.14%), Hims & Hers Health, Inc. (24.22%), Option Care Health, Inc. (3.46%), Sotera Health (4.33%), Veracyte, Inc. (3.29%), BrightSpring Health Services, Inc. (13.17%), LifeStance Health Group, Inc. (9.88%), Surgery Partners, Inc. (14.72%), Privia Health Group, Inc. (5.62%), GeneDx Holdings Corp. (9.79%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.32 billion), Spotify Technology S.A. ($4.06 billion), Canadian Natural Resources Limited ($3.45 billion), Reddit, Inc. ($2.79 billion), International Paper ($2.70 billion), Cencora, Inc. ($2.27 billion), SoFi Technologies, Inc. ($2.21 billion), Lululemon Athletica Inc. ($2.13 billion), and Rivian Automotive, Inc. ($2.05 billion). View all of the most shorted stocks. What does it mean to sell short Guardant Health stock? Short selling GH is an investing strategy that aims to generate trading profit from Guardant Health as its price is falling. GH shares are trading up $0.27 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Guardant Health? A short squeeze for Guardant Health occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GH, which in turn drives the price of the stock up even further. How often is Guardant Health's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GH, twice per month. The most recent reporting period available is December, 15 2024. More Short Interest Resources from MarketBeat Related Companies FMS Short Interest Data HIMS Short Interest Data OPCH Short Interest Data SHC Short Interest Data VCYT Short Interest Data BTSG Short Interest Data LFST Short Interest Data SGRY Short Interest Data PRVA Short Interest Data WGS Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GH) was last updated on 1/7/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredElon Musk says U.S. government is going bankruptIn 2016, Jeff Brown called Nvidia at a split-adjusted 66 cents. The company just became the world's third $...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredAmazon coin set to soar 25X – starting January 20thThis tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guardant Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guardant Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GH Stock Alerts